 |
 |
 |
|
| What we do The Texas Cancer Genetics Network (TCGN) is a study conducted at The University of Texas M. D. Anderson Cancer Center and is one of the 14 centers selected by the National Cancer Institute to lead the nation in the study of genetics and cancer. This alliance of research centers is called the Cancer Genetics Network (CGN) and the regional centers and their affiliated clinics are inviting volunteers who have had cancer (or whose family history places them at high risk), to join the network's research efforts. In April 2007, the NCI has awarded the CGN Data Coordinating Center (DCC) contract to Massachusetts General Hospital (MGH). The MGH received approval from the NCI and the CGN Steering Committee to begin a Biospecimen Repository of CGN participants. The TCGN has not routinely collected and stored biospecimens from the registrants. Now, we are inviting volunteers to participate in the Bispecimen repository. For more details please contact us by telephone at 1-877-900-8894 or by email at humancancergenetics@mdanderson.org. Who we are The Texas Cancer Genetics Network was recently reviewed by the NCI and includes not only The University of Texas M.D. Anderson Cancer Center but also The University of Texas Health Science Center at San Antonio, The University of Texas Southwestern Medical Center at Dallas, and Baylor College of Medicine at Houston as independent participants. |
Our Goals The Cancer Genetics Network will allow researchers to explore, more than ever before, the key role gene mutations play in human cancer. It will capitalize on recent advances in human genetics research and support a broad range of basic and clinical research in a nationwide quest to find genetic susceptibility factors for cancer as well as prevention strategies for the disease. The Benefits The research generated from the Cancer Genetics Network centers will make possible an unprecedented collaboration among leading clinicians, basic scientists, epidemiologists, genetic counselors and community organizations. The Massachusetts General Hospital will coordinate data collection efforts for one of the most comprehensive human cancer genetics research databases ever undertaken. The system will contain data on hundreds of thousands of people who are genetically predisposed to cancer, as well as contain tissue samples, educational materials and other resources designed to increase the world's understanding of the genetic basis of cancer. |
||
